{
    "clinical_study": {
        "@rank": "15105", 
        "arm_group": {
            "arm_group_label": "Percentage of hair reduction", 
            "arm_group_type": "Experimental"
        }, 
        "brief_summary": {
            "textblock": "This is a clinical study to determine the efficacy and safety of the Glide, hair removal\n      photo-depilation device, for removing facial hairs. During the first stage, the subjects\n      will perform up to 6 face treatments, two weeks apart.  The treatment's safety and\n      efficiency will be evaluated at 4 weeks of after last treatment and at 12 weeks after last\n      treatment."
        }, 
        "brief_title": "Clinical Evaluation of Silk'n Glide for Face", 
        "completion_date": {
            "#text": "June 2014", 
            "@type": "Anticipated"
        }, 
        "condition": "Hirsutism", 
        "condition_browse": {
            "mesh_term": [
                "Hirsutism", 
                "Hypertrichosis"
            ]
        }, 
        "detailed_description": {
            "textblock": "Study efficacy assessment:\n\n      Comparison of hair counts before treatments to 4 and 12 weeks follow up visits.\n\n      Study safety assessment:\n\n        1. Reported errors and near errors using the device\n\n        2. Device malfunctions which relate to device safety\n\n        3. Device related adverse events\n\n        4. Non device related adverse events (secondary endpoint)"
        }, 
        "eligibility": {
            "criteria": {
                "textblock": "Inclusion Criteria:\n\n          1. Presence of unwanted hairs on the face\n\n          2. Skin Type I to IV (Fitzpatrick)\n\n          3. Adults older than 21 years of age but not more than 60 years of age.\n\n          4. Must be either post-menopausal or surgically steri-lized, or using a    medically\n             acceptable form of birth control (i.e., oral contraceptives, IUD, contraceptive\n             implant, barrier methods with spermicide or absti-nence).\n\n          5. Informed consent agreement by the subject.\n\n          6. Willingness to follow the treatment schedule and post treatment care.\n\n        Exclusion Criteria:\n\n          1. Malignant or pre-malignant pigmented lesions in the area to be treated.\n\n          2. Scarring or infection of the area to be treated.\n\n          3. Known photosensitivity.\n\n          4. Pregnancy or lactating\n\n          5. Subjects with Diabetes (Type I or II).\n\n          6. Presence of a suntan in the area to be treated.\n\n          7. Use of medication known to induce photosensitivity.\n\n          8. Subject is on anticoagulative medication or throm-boembolic condition.\n\n          9. Subjects with a pacemaker or internal defibrillator.\n\n         10. Use of NSAIDS two weeks prior to, and two weeks following the treatment.\n\n         11. Subjects that use waxing or other methods of photo-epilation 3 months prior to\n             treatment.\n\n         12. Subjects that have been exposed to strong sunlight or an artificial tanning machine\n             during the past 4 weeks\n\n         13. Subjects wearing a tattoo or permanent makeup on the area to be treated\n\n         14. Subjects with dark brown or black spots, such as large freckles, birth marks, moles\n             or warts on the area to be treated\n\n         15. Subjects with Eczema, psoriasis, lesions, open wounds or active infections, such as\n             cold sores in the area to be treated\n\n         16. Subjects with history of keloidal scar formation\n\n         17. Subjects with history of herpes outbreaks in the area of treatment, unless you have\n             consulted your physician and received preventative treatment before using GlideTM\n\n         18. Subjects with epilepsy\n\n         19. Subjects using incontinence device, insulin pump, other active devices [NB: Protocol\n             excludes pace-makers and internal defibrillators.]\n\n         20. Subjects with a history of skin cancer or areas of po-tential skin malignancies\n\n         21. Subjects who have received radiation therapy or chemotherapy treatments within the\n             past 3 months"
            }, 
            "gender": "Both", 
            "healthy_volunteers": "Accepts Healthy Volunteers", 
            "maximum_age": "60 Years", 
            "minimum_age": "21 Years"
        }, 
        "enrollment": {
            "#text": "16", 
            "@type": "Actual"
        }, 
        "firstreceived_date": "March 23, 2014", 
        "has_expanded_access": "No", 
        "id_info": {
            "nct_id": "NCT02103608", 
            "org_study_id": "DO105306A"
        }, 
        "intervention": {
            "arm_group_label": "Percentage of hair reduction", 
            "intervention_name": "Glide", 
            "intervention_type": "Device"
        }, 
        "is_fda_regulated": "No", 
        "keyword": "at Home Photo depilation device, Silk'n.", 
        "lastchanged_date": "April 3, 2014", 
        "number_of_arms": "1", 
        "official_title": "Clinical Evaluation of Silk'n Glide for Face", 
        "overall_official": {
            "affiliation": "Tennessee Clinical Research Center", 
            "last_name": "Michael H Gold, MD", 
            "role": "Principal Investigator"
        }, 
        "overall_status": "Active, not recruiting", 
        "oversight_info": {
            "authority": "United States: Institutional Review Board", 
            "has_dmc": "Yes"
        }, 
        "phase": "N/A", 
        "primary_completion_date": {
            "#text": "April 2014", 
            "@type": "Anticipated"
        }, 
        "primary_outcome": {
            "description": "Hair count is going to be preformed and base line and compare with the count at 4 weeks and 12 weeks. % of hair reducation is going to be calculated.", 
            "measure": "1. Comparison of hair counts before treatments to 4 and 12 weeks follow up visits.", 
            "safety_issue": "No", 
            "time_frame": "4 weeks and 12 weeks post treatment"
        }, 
        "required_header": {
            "download_date": "ClinicalTrials.gov processed this data on June 04, 2014", 
            "link_text": "Link to the current ClinicalTrials.gov record.", 
            "url": "http://clinicaltrials.gov/show/NCT02103608"
        }, 
        "responsible_party": {
            "responsible_party_type": "Sponsor"
        }, 
        "source": "Home Skinovations Ltd.", 
        "sponsors": {
            "lead_sponsor": {
                "agency": "Home Skinovations Ltd.", 
                "agency_class": "Industry"
            }
        }, 
        "start_date": "September 2013", 
        "study_design": "Endpoint Classification: Safety/Efficacy Study, Intervention Model: Single Group Assignment, Masking: Single Blind (Outcomes Assessor), Primary Purpose: Treatment", 
        "study_type": "Interventional", 
        "verification_date": "March 2014"
    }
}